Knight Therapeutics Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Knight Therapeutics has a total shareholder equity of CA$762.8M and total debt of CA$51.0M, which brings its debt-to-equity ratio to 6.7%. Its total assets and total liabilities are CA$945.4M and CA$182.6M respectively. Knight Therapeutics's EBIT is CA$8.0M making its interest coverage ratio 41.5. It has cash and short-term investments of CA$157.5M.
Belangrijke informatie
6.7%
Verhouding schuld/eigen vermogen
CA$50.95m
Schuld
| Rente dekkingsratio | 41.5x |
| Contant | CA$157.47m |
| Aandelen | CA$762.80m |
| Totaal verplichtingen | CA$182.56m |
| Totaal activa | CA$945.36m |
Recente financiële gezondheidsupdates
Does Knight Therapeutics (TSE:GUD) Have A Healthy Balance Sheet?
May 28
Knight Therapeutics (TSE:GUD) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Feb 03
Recent updates
Does Knight Therapeutics (TSE:GUD) Have A Healthy Balance Sheet?
May 28Shareholders May Not Be So Generous With Knight Therapeutics Inc.'s (TSE:GUD) CEO Compensation And Here's Why
May 07Calculating The Fair Value Of Knight Therapeutics Inc. (TSE:GUD)
Apr 07Read This Before Selling Knight Therapeutics Inc. (TSE:GUD) Shares
Mar 20If You Had Bought Knight Therapeutics' (TSE:GUD) Shares Three Years Ago You Would Be Down 34%
Mar 02Knight Therapeutics (TSE:GUD) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Feb 03Knight Therapeutics's (TSE:GUD) Earnings Are Growing But Is There More To The Story?
Jan 19What Type Of Shareholders Own The Most Number of Knight Therapeutics Inc. (TSE:GUD) Shares?
Jan 04A Look At The Fair Value Of Knight Therapeutics Inc. (TSE:GUD)
Dec 20The Founder of Knight Therapeutics Inc. (TSE:GUD), Jonathan Goodman, Just Bought A Few More Shares
Dec 07What Type Of Returns Would Knight Therapeutics'(TSE:GUD) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Dec 02Need To Know: The Consensus Just Cut Its Knight Therapeutics Inc. (TSE:GUD) Estimates For 2021
Nov 17Analyse van de financiële positie
Kortlopende schulden: GUD's short term assets (CA$360.6M) exceed its short term liabilities (CA$105.8M).
Langlopende schulden: GUD's short term assets (CA$360.6M) exceed its long term liabilities (CA$76.7M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: GUD has more cash than its total debt.
Schuld verminderen: GUD's debt to equity ratio has increased from 0% to 6.7% over the past 5 years.
Schuldendekking: GUD's debt is well covered by operating cash flow (123.5%).
Rentedekking: GUD's interest payments on its debt are well covered by EBIT (41.5x coverage).